Wealth Enhancement Advisory Services LLC Takes $440,000 Position in Tempus AI, Inc. (NASDAQ:TEM)

Wealth Enhancement Advisory Services LLC purchased a new stake in Tempus AI, Inc. (NASDAQ:TEM) during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 9,121 shares of the company’s stock, valued at approximately $440,000.

Other hedge funds have also made changes to their positions in the company. Operose Advisors LLC bought a new stake in shares of Tempus AI in the fourth quarter valued at about $25,000. Farther Finance Advisors LLC bought a new stake in shares of Tempus AI in the fourth quarter valued at about $34,000. Prestige Wealth Management Group LLC lifted its stake in shares of Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after buying an additional 965 shares during the period. NewEdge Advisors LLC bought a new stake in shares of Tempus AI in the fourth quarter valued at about $49,000. Finally, GAMMA Investing LLC bought a new stake in shares of Tempus AI in the first quarter valued at about $105,000. Institutional investors own 24.22% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on TEM. Bank of America raised their price target on shares of Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 25th. BTIG Research assumed coverage on shares of Tempus AI in a research note on Monday, April 21st. They set a “buy” rating and a $60.00 price target for the company. Morgan Stanley raised their price target on shares of Tempus AI from $60.00 to $65.00 and gave the stock an “overweight” rating in a research note on Friday, May 9th. Guggenheim raised their price target on shares of Tempus AI from $65.00 to $75.00 and gave the stock a “buy” rating in a research note on Monday, June 30th. Finally, Piper Sandler raised their price target on shares of Tempus AI from $55.00 to $70.00 and gave the stock a “neutral” rating in a research note on Thursday, May 15th. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, Tempus AI presently has a consensus rating of “Moderate Buy” and an average price target of $63.67.

Insider Activity at Tempus AI

In related news, EVP Erik Phelps sold 51,317 shares of the company’s stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $72.56, for a total value of $3,723,561.52. Following the transaction, the executive vice president owned 97,779 shares in the company, valued at approximately $7,094,844.24. This represents a 34.42% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Ryan Fukushima sold 20,000 shares of the company’s stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $52.36, for a total transaction of $1,047,200.00. Following the completion of the transaction, the chief operating officer owned 884,460 shares in the company, valued at approximately $46,310,325.60. This trade represents a 2.21% decrease in their position. The disclosure for this sale can be found here. Insiders sold 607,522 shares of company stock worth $41,300,238 over the last ninety days. Company insiders own 27.60% of the company’s stock.

Tempus AI Stock Performance

Shares of Tempus AI stock opened at $60.65 on Monday. The firm has a 50 day simple moving average of $62.53 and a 200 day simple moving average of $54.27. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.71 and a quick ratio of 1.56. Tempus AI, Inc. has a fifty-two week low of $30.81 and a fifty-two week high of $91.45. The firm has a market cap of $10.50 billion and a P/E ratio of -7.78.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.03. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The business had revenue of $255.74 million for the quarter, compared to analysts’ expectations of $248.13 million. The firm’s quarterly revenue was up 75.4% compared to the same quarter last year. Sell-side analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.